ABBOTT PARK, Ill., April 21, 2016
/PRNewswire/ -- Abbott (NYSE: ABT) today announced the
global launch of AlinIQ, the first in a series of new innovations
that Abbott will be bringing to diagnostics customers around the
world over the next few years. AlinIQ is a first-of-its-kind
professional services and informatics solution that will enable
labs to deliver greater overall productivity with their existing
resources.
In addition to AlinIQ, Abbott is preparing to launch
next-generation systems in point of care testing, immunoassay,
clinical chemistry, hematology, blood screening and molecular
diagnostics. Each system will be built with a consistent system
design and intuitive interface, along with flexible automation, to
provide Abbott's customers a unified experience from system to
system.
"Healthier hospitals – and healthier patients – begin with
healthier labs. AlinIQ will help our lab partners transform their
operations to maximize throughput and capacity, reduce unexpected
downtime and better manage the flow of data throughout hospital
networks," says Jaime Contreras,
senior vice president, commercial operations, Diagnostics, Abbott.
"Abbott's goal is to help labs get the right diagnosis to patients
at the right time so they may get back to doing what they
love."
MEETING THE NEEDS OF HOSPITAL LABORATORIES – NOW AND IN THE
FUTURE
Every day, hospital laboratories are asked to do
more with less. Among their challenges are increases in testing
volumes driven by the health needs of an aging and growing
population and the rising prevalence of chronic
disease.1 At the same time, by 2018, nearly 10 percent
of the world's population will be 65 and older and global health
care spending is predicted to accelerate, rising an average of 5.2
percent per year until it reaches $9.3
trillion.1 In this environment of increased
spending overall and greater demands for testing, labs are under
pressure to manage costs and demonstrate the value they can bring
in improving the delivery of health care to patients.
AlinIQ was created to help labs adapt to these challenges,
address cost pressures and highlight the value that diagnostics
testing brings to the health care system. Abbott's researchers,
engineers and designers worked side-by-side with laboratorians
around the world to develop AlinIQ, which includes four key
offerings that combine professional service experts with processes
and tools:
- Proactive, preventive services: The AlinIQ Always On
services deliver predictive alerts to labs, enabling the
detection and prevention of instrument downtime up to three days in
advance.
- Data harmonization services: The AlinIQ AMS (Analyzer
Management System) provides labs and hospital networks the ability
to integrate different software systems into a single standardized
platform to optimize sample processing time, workflow efficiency
and quality results.
- Operational services: The AlinIQ BIS (Business
Intelligence System) provides the tools to optimize throughput and
capacity of existing systems to help labs absorb volume increases
without additional budget. By delivering intelligent insights,
AlinIQ BIS helps labs improve operations and operational expense
performance and communicate the lab's value to the broader health
care organization.
- Inventory optimization and product availability
services: The AlinIQ IMS (Inventory Management System),
which combines innovative RFID technology and streamlined process
consulting, allows labs to get ahead of operational needs, helping
avoid shortages of critical items, reduce waste and time taken for
manual processes.
"Complementary services and support are critical for labs to
successfully implement new technological advances," says Contreras.
"This is why AlinIQ offers both professional services and
informatics tools to help labs adapt within an ever changing
business environment."
To learn more about AlinIQ, please visit
www.abbottdiagnostics.com/AlinIQ.
About Abbott:
At Abbott, we're committed to helping
you live your best possible life through the power of health. For
more than 125 years, we've brought new products and technologies to
the world -- in nutrition, diagnostics, medical devices and branded
generic pharmaceuticals -- that create more possibilities for more
people at all stages of life. Today, 74,000 of us are working to
help people live not just longer, but better, in the more than 150
countries we serve.
Connect with us at www.abbott.com, on Facebook at
www.facebook.com/Abbott and on Twitter @AbbottNews and
@AbbottGlobal.
AlinIQ is a trademark of Abbott Laboratories in various
jurisdictions.
i Global healthcare spending is predicted to
accelerate, rising an average of 5.2 percent per year in 2014-2018,
to $9.3 trillion. 2015 Global Health
Care Outlook: Common Goals, Competing Priorities. Deloitte.
Website:
http://www2.deloitte.com/content/dam/Deloitte/global/Documents/Life-Sciences-Health-Care/gx-lshc-2015-health-care-outlook-global.pdf.
Logo - http://photos.prnewswire.com/prnh/20150928/271488LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/abbott-introduces-new-services-and-tools-to-help-labs-deliver-greater-operational-productivity-300255028.html
SOURCE Abbott